2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| M33 Growth I L.P. | Director | 5,444,207 | Nov 20, 2025 |
| M33 Growth I GP LLC | Director | 5,444,207 | Nov 20, 2025 |
| Toi M, Llc | Director | 5,444,207 | Nov 20, 2025 |
| Barasch Richard A | Director | 2,635,881 | Jul 28, 2025 |
| Virnich Daniel | CEO | 1,799,984 | Nov 19, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | STOLPER MARK | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2026 | Jan 6, 2026 | Carter Robert Ross | CFO | Sell | 52.5 | -244 | -0.10% | ✗ | $895.5 |
| Jan 2, 2026 | Jan 5, 2026 | Carter Robert Ross | CFO | Sell | 52.5 | -247 | -0.10% | ✗ | $879.3 |
| Dec 15, 2025 | Dec 16, 2025 | Hively Brad | Director | Sell | 22.5 | -13,333 | -1.91% | ✗ | $50.3K |
| Dec 1, 2025 | Ling Gabriel | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 20, 2025 | Nov 24, 2025 | McGeorge Anne | Director | Neutral | 90.0 | +108,024 | 58.92% | ✗ | - |
| Nov 20, 2025 | Nov 24, 2025 | Kaushal Mohit | Director | Neutral | 90.0 | +91,049 | 51.37% | ✗ | - |
| Nov 20, 2025 | Nov 24, 2025 | Ling Gabriel | Director | Neutral | 90.0 | +83,333 | 33.31% | ✗ | - |
| Nov 20, 2025 | Nov 24, 2025 | Johnson Karen Marie | Director | Neutral | 90.0 | +84,877 | 41.73% | ✗ | - |
| Nov 20, 2025 | Nov 24, 2025 | Pacala Mark L | Director | Neutral | 90.0 | +81,790 | 46.74% | ✗ | - |
| Nov 20, 2025 | Nov 24, 2025 | Hively Brad | Director | Neutral | 90.0 | +74,074 | 11.89% | ✗ | - |
| Nov 18, 2025 | Nov 20, 2025 | Pacala Mark L | Director | Sell | 22.5 | -50,000 | -22.23% | ✗ | $200K |
| Nov 18, 2025 | Nov 20, 2025 | Ling Gabriel | Director | Neutral | 90.0 | +141,149 | 129.43% | ✗ | - |
| Nov 18, 2025 | Nov 20, 2025 | M33 Growth I L.P. | Director | Neutral | 27.5 | -3,079,074 | -36.13% | ✗ | - |
| Nov 17, 2025 | Nov 19, 2025 | Virnich Daniel | CEO | Neutral | 60.0 | +6,464 | 0.36% | ✗ | - |
| Nov 17, 2025 | Nov 19, 2025 | Podnos Yale | Chief Medical Officer | Neutral | 67.5 | +2,086 | 0.88% | ✗ | - |
| Nov 17, 2025 | Nov 19, 2025 | Carter Robert Ross | CFO | Neutral | 55.0 | +195 | 0.08% | ✗ | - |
| Nov 12, 2025 | Nov 14, 2025 | Virnich Daniel | CEO | Neutral | 60.0 | +6,211 | 0.35% | ✗ | - |
| Nov 12, 2025 | Nov 14, 2025 | Podnos Yale | Chief Medical Officer | Neutral | 67.5 | +1,508 | 0.64% | ✗ | - |
| Sep 4, 2025 | Sep 5, 2025 | M33 Growth I L.P. | Director | Sell | 15.0 | -6,700,000 | -44.01% | ✗ | $20.7M |
| Aug 19, 2025 | Aug 21, 2025 | Hively Brad | Director | Sell | 22.5 | -20,221 | -3.14% | ✗ | $82.1K |
| Aug 14, 2025 | BARASCH RICHARD A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 24, 2025 | Jul 28, 2025 | BARASCH RICHARD A | Director | Neutral | 27.5 | -287,756 | -9.84% | ✗ | - |
| Jul 22, 2025 | Jul 24, 2025 | England Kristin | Chief Administrative Officer | Neutral | 90.0 | +98,037 | 100.00% | ✗ | - |
| Jul 22, 2025 | England Kristin | Chief Administrative Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 17, 2025 | Jun 24, 2025 | BARASCH RICHARD A | Director | Sell | 20.0 | -311,128 | -9.62% | ✗ | $813.7K |
| Jun 17, 2025 | Jun 20, 2025 | BARASCH RICHARD A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2025 | Jun 9, 2025 | M33 Growth I L.P. | Director | Sell | 17.5 | -750,000 | -4.70% | ✗ | $2.3M |
| Jun 3, 2025 | Jun 5, 2025 | Hively Brad | Director | Sell | 16.3 | -1,976,137 | -76.61% | ✗ | $5.7M |
| May 21, 2025 | May 23, 2025 | Langsam Jeffrey | Chief Clinical Officer | Neutral | 90.0 | +57,380 | 100.00% | ✗ | - |
| May 23, 2025 | Langsam Jeffrey | Chief Clinical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 20, 2025 | May 22, 2025 | M33 Growth I L.P. | Director | Sell | 16.3 | -2,000,000 | -11.13% | ✗ | $5.4M |
| May 21, 2025 | May 22, 2025 | Virnich Daniel | CEO | Sell | 42.5 | -20,388 | -1.13% | ✗ | $54.5K |
| May 21, 2025 | May 22, 2025 | Podnos Yale | Chief Medical Officer | Sell | 50.0 | -1,801 | -0.76% | ✗ | $4.8K |
| May 21, 2025 | May 22, 2025 | Carter Robert Ross | CFO | Sell | 50.0 | -1,601 | -0.68% | ✗ | $4.3K |
| May 21, 2025 | May 22, 2025 | Castle Jeremy | COO | Sell | 46.3 | -5,636 | -2.23% | ✗ | $15.1K |
| Mar 31, 2025 | Apr 2, 2025 | Podnos Yale | Chief Medical Officer | Neutral | 90.0 | +157,088 | 198.72% | ✗ | - |
| Mar 31, 2025 | Apr 2, 2025 | Carter Robert Ross | CFO | Neutral | 90.0 | +197,368 | 500.85% | ✗ | - |
| Mar 31, 2025 | Apr 2, 2025 | Castle Jeremy | COO | Neutral | 90.0 | +162,281 | 179.54% | ✗ | - |
| Mar 31, 2025 | Apr 2, 2025 | Virnich Daniel | CEO | Neutral | 90.0 | +1,083,334 | 149.56% | ✗ | - |
| Mar 26, 2025 | Mar 28, 2025 | M33 Growth I L.P. | Director | Neutral | 90.0 | +2,716,898 | 19.83% | ✗ | - |
| Mar 26, 2025 | Mar 28, 2025 | Virnich Daniel | CEO | Buy | 83.8 | +22,640 | 3.23% | ✗ | $23.6K |
| Mar 26, 2025 | Mar 28, 2025 | Podnos Yale | Chief Medical Officer | Buy | 90.0 | +9,056 | 12.94% | ✗ | $9.4K |
| Mar 26, 2025 | Mar 28, 2025 | Pacala Mark L | Director | Buy | 95.0 | +90,562 | 67.38% | ✗ | $94.3K |
| Mar 26, 2025 | Mar 28, 2025 | Johnson Karen Marie | Director | Buy | 91.3 | +36,224 | 21.67% | ✗ | $37.7K |
| Mar 26, 2025 | Mar 28, 2025 | Hively Brad | Director | Buy | 77.5 | +9,056 | 1.36% | ✗ | $9.4K |
| Mar 26, 2025 | Mar 28, 2025 | Castle Jeremy | COO | Buy | 90.0 | +9,056 | 11.13% | ✗ | $9.4K |
| Mar 26, 2025 | Mar 28, 2025 | Carter Robert Ross | CFO | Buy | 90.0 | +9,056 | 29.84% | ✗ | $9.4K |
| Mar 26, 2025 | Mar 28, 2025 | BARASCH RICHARD A | Director | Buy | 100.0 | +1,358,448 | 325.62% | ✗ | $1.4M |
| Mar 19, 2025 | Mar 20, 2025 | Virnich Daniel | CEO | Sell | 47.5 | -10,261 | -1.44% | ✗ | $9.1K |
| Mar 19, 2025 | Mar 20, 2025 | Podnos Yale | Chief Medical Officer | Sell | 47.5 | -2,975 | -4.08% | ✗ | $2.6K |
| Mar 19, 2025 | Mar 20, 2025 | Carter Robert Ross | CFO | Sell | 47.5 | -1,150 | -3.65% | ✗ | $1K |
| Jan 6, 2025 | Jan 7, 2025 | Carter Robert Ross | CFO | Sell | 50.0 | -258 | -0.81% | ✗ | $86.4 |
| Dec 3, 2024 | Dec 5, 2024 | Castle Jeremy | COO | Sell | 47.5 | -1,130 | -1.37% | ✗ | $180.8 |
| Nov 12, 2024 | Dec 2, 2024 | Hively Brad | Director | Buy | 22.5 | -53,450 | -7.42% | ✗ | $50K |
| Nov 22, 2024 | Nov 25, 2024 | BARASCH RICHARD A | Director | Neutral | 90.0 | +80,000 | 23.73% | ✗ | - |
| Nov 22, 2024 | Nov 25, 2024 | Pacala Mark L | Director | Neutral | 90.0 | +50,000 | 59.24% | ✗ | - |
| Nov 22, 2024 | Nov 25, 2024 | McGeorge Anne | Director | Neutral | 90.0 | +56,000 | 43.97% | ✗ | - |
| Nov 22, 2024 | Nov 25, 2024 | Johnson Karen Marie | Director | Neutral | 90.0 | +52,000 | 45.14% | ✗ | - |
| Nov 22, 2024 | Nov 25, 2024 | Kaushal Mohit | Director | Neutral | 90.0 | +56,000 | 46.18% | ✗ | - |
| Nov 22, 2024 | Nov 25, 2024 | Ling Gabriel | Director | Neutral | 90.0 | +40,000 | 57.92% | ✗ | - |
| Nov 22, 2024 | Nov 25, 2024 | Hively Brad | Director | Neutral | 85.0 | +44,000 | 6.51% | ✗ | - |
| Nov 20, 2024 | Nov 21, 2024 | Virnich Daniel | CEO | Sell | 47.5 | -9,727 | -1.35% | ✗ | $1.3K |
| Nov 20, 2024 | Nov 21, 2024 | Carter Robert Ross | CFO | Sell | 50.0 | -235 | -0.73% | ✗ | $32 |
| Nov 20, 2024 | Nov 21, 2024 | Podnos Yale | Chief Medical Officer | Sell | 47.5 | -3,002 | -3.95% | ✗ | $408 |
| Nov 12, 2024 | Nov 18, 2024 | Podnos Yale | Chief Medical Officer | Neutral | 27.5 | -28,398 | -27.21% | ✗ | - |
| Nov 12, 2024 | Nov 18, 2024 | Pacala Mark L | Director | Neutral | 27.5 | -50,620 | -37.49% | ✗ | - |
| Nov 12, 2024 | Nov 18, 2024 | Virnich Daniel | CEO | Neutral | 27.5 | -195,236 | -21.29% | ✗ | - |
| Sep 30, 2024 | Carter Robert Ross | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |